Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will exclude (a) BGI Group, (b) MGI Tech and (c) other state-linked genomics companies blacklisted by the United States from public sector health bodies.

The Government continues to review the evolving national security risks in the life sciences sector, including engaging with partners and allies, while ensuring that the United Kingdom is at the forefront of innovation.

The Procurement Act will come into force in 2025 and will include a Debarment Review Service, which aims to safeguard public procurement from suppliers deemed to pose a risk. As with all national security risks, there will be engagement with colleagues across Cabinet and Parliament to ensure we maintain a robust approach to managing these risks as they evolve.